The price of progress: Funding and financing Alzheimer's disease drug development

INTRODUCTION: Advancing research and treatment for Alzheimer's disease (AD) and the search for effective treatments depend on a complex financial ecosystem involving federal, state, industry, advocacy, venture capital, and philanthropy funding approaches. METHODS: We conducted an expert review...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (N Y)
Autors principals: Cummings, Jeffrey, Reiber, Carl, Kumar, Parvesh
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018
Matèries:
Special Issue from the Centers of Biomedical Research Excellence (COBRE) and Center for Neurodegeneration and Translational Neuroscience (CNTN)
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6118094/
https://ncbi.nlm.nih.gov/pubmed/30175227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.04.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars